Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Minh Quan Pham has a total of 431 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Natural PTP1B and α-Glucosidase Inhibitors from Erythrina variegata: Isolation, Biological Evaluation and Molecular Modelling

    by Ngoc Thao Vy Trinh, Thi Thuy Do, Phi Hung Nguyen, Minh Quan Pham, Thi Thuy Huong Le, Phu Chi Hieu Truong, Le Minh Hoang, Thi Viet Hoa Truong, Dao Cuong To, Nien Vinh Lam

    Erythrina variegata L. has long been used in traditional medicine; however, compound-specific enzyme inhibitory data for constituents of E. variegata remain limited. In present study, the phytochemical investigation of the stems of E. variegata yielded two known isoflavonoids, erythribyssin H (1) and eryvarin R (2), which were evaluated for their in vitro inhibitory activities against protein tyrosine phosphatase 1B (PTP1B) and α-glucosidase. Compounds 1 and 2 exhibited inhibitory activity against PTP1B with IC50 values of 4.12 ± 0.99 and 4.36 ± 0.74 µM, respectively. In the α-glucosidase assay, compounds 1 and 2 showed IC50 values of 96.33 ± 0.29 and 101.09 ± 0.87 µM, respectively. Exploratory molecular docking was performed to examine possible interactions with the selected enzyme structures, while absorption, distribution, metabolism, excretion and toxicity (ADMET) predictions provided preliminary estimates of physico-chemical, pharmacokinetic and toxicity-related properties. These findings provide compound-specific in vitro evidence of enzyme inhibition by two known constituents of E. variegata.

  • Open Access

    Sesquiterpene‐Rich Essential Oil From Magnolia officinalis Stem Bark: Chemical Composition, Biological Activities, and In Silico Approach

    by Nguyen Thi Kim Thanh, Phan Hong Minh, Huynh Thi Ngoc Ni, Tran Quang Hai, Le The Hoai, Le Ba Vinh, Pham Minh Quan, Nguyen Dinh Luyen, Ninh The Son

    The stem bark essential oil of Magnolia officinalis ( M. officinalis ) Rehder & E.H. Wilson was investigated for its chemical composition, biological activities, and in silico interactions. From the GC–FID/MS analysis, the sample was dominated by sesquiterpene hydrocarbons (85.38% ± 0.04%). The major constituents were ( E )‐caryophyllene (21.69% ± 0.020%), α‐selinene (10.13% ± 0.016%), ( Z )‐β‐farnesene (7.07% ± 0.011%), β‐selinene (6.81% ± 0.006%), γ‐muurolene (6.15% ± 0.008%), α‐humulene (6.13% ± 0.007%), and δ‐cadinene (5.26% ± 0.006%). Remarkably, this is the first report demonstrating the α‐glucosidase inhibitory activity of M. officinalis stem bark essential oil, which exhibited significant activity (IC 50 = 188.98 ± 5.60 µg/mL), exceeding that of the standard compound acarbose (IC 50 = 240.06 ± 4.32 µg/mL). In addition, the essential oil possessed cytotoxicity against MCF‐7 and HepG2 cancer cell lines, DPPH radical scavenging, anti‐inflammatory activity against NO and PGE2 productions, and antimicrobial activities. Molecular docking analysis revealed that the major compounds exhibited moderate to strong binding affinities toward α‐glucosidase, with binding energies ranging from –5.6 to –6.9 kcal/mol, comparable to acarbose, and predominantly stabilized by hydrophobic interactions. In addition, γ‐muurolene and δ‐cadinene emerged as the most promising candidates, combining strong binding affinity with optimal ADMET characteristics.

  • Open Access

    An Integrated Computational Workflow for Discovering Alkaloid-Derived Ligands of Cyclin-Dependent Kinase 2

    by Anh Tuan Do, Quoc Long Pham, Huong Thi Thu Phung, Minh Quan Pham

    Background/Objectives: Cyclin-dependent kinase 2 (CDK2) is a key regulator of cell-cycle progression and a potential anticancer target. This study aimed to identify alkaloid-derived CDK2 ligands using an integrated computational workflow and to obtain preliminary evidence of their effects on cancer-cell viability. Methods: Molecular docking with mVina and fast pulling of ligand (FPL) simulations were benchmarked using 20 experimentally characterized CDK2 inhibitors. A library of 2692 PubChem-derived alkaloids was screened, followed by ADMET evaluation, 100 ns molecular dynamics simulations, and FPL-based relative-affinity re-ranking. The three prioritized compounds were evaluated in HepG2 and HGC-27 cells using an MTT assay after 48 h of exposure. Results: Docking and FPL showed correlations with experimental affinity data of RDock = 0.549 ± 0.180 and RW = −0.676 ± 0.119, respectively. CID 636885, CID 46184320, and CID 101691758 were prioritized for detailed evaluation. All three compounds reduced cell viability, with lower IC50 values observed in HepG2 cells than in HGC-27 cells. CID 101691758 exhibited the highest growth-inhibitory activity among the tested compounds, with IC50 values of 15.37 ± 0.46 µg mL−1 in HepG2 cells and 52.64 ± 1.33 µg mL−1 in HGC-27 cells. Conclusions: The workflow identified three preliminary alkaloid hits, with CID 101691758 showing the most favorable combined computational and cell-viability profile. However, the MTT assay does not establish direct CDK2 inhibition or kinase selectivity. Biochemical CDK2 inhibition, target-engagement, and kinase-panel studies are therefore required.

  • Open Access

    Integrated in silico approaches reveal xanthone scaffold compounds as promising CDK2 inhibitors

    by Le Thi Thuy Huong, Bui Nguyen Thanh Long, Tran Van Lang, Pham Minh Quan

    Cyclin-dependent kinase 2 is a pivotal regulator of the eukaryotic cell cycle, and its hyperactivation is a hallmark of various human malignancies. Consequently, identifying potent CDK2 inhibitors remains a primary objective in anticancer drug discovery. In this study, we employed an integrated in silico approach to evaluate a library of 3000 xanthone derivatives as potential CDK2 inhibitors. Initial high-throughput molecular docking identified compounds 313 and 481 as the potential inhibitors. Subsequent 20 ns molecular dynamics simulations confirmed the structural stability of the complexes, with all-atom RMSD values equilibrating at approximately 0.2 nm. Interaction analysis revealed that these inhibitors establish robust hydrogen bonds with essential residues, including Leu83 and Asp145, supported by an extensive hydrophobic network. While ADMET profiling indicated low acute toxicity and no tumorigenic potential, challenges regarding oral bioavailability and predicted mutagenicity were observed. These findings highlight compounds 313 and 481 as promising natural lead scaffolds that merit further structural optimization for the development of novel targeted cancer therapies.

  • Inhibitors of Nitric Oxide Production and α-Glucosidase from Pseudotsuga menziesii: An Integrated In Vitro and In Silico Study

    by Dao Cuong To, Le Minh Hoang, Phi Hung Nguyen, Thuy Mi Pham Lam, Hoa Thi Nguyen, Thi Viet Hoa Truong, Minh Quan Pham, Thi Thuy Do, Phuong Dai Nguyen Nguyen, Truong Nhan Ngu, et al.

  • Open Access

    Structure-Based Drug Design Targeting Topoisomerase II Alpha: Discovery of Potential Antitumor Xanthone Derivatives

    by Thi Thuy Huong Le, Thi Nguyet Hang Nguyen, Minh Quan Pham, Thi Thu Thuy Tran, Tu Thi Dinh, Thi Hoai Van Tran, Van Lang Tran, Quoc Long Pham

    Cancer represents a major global health challenge, contributing to an estimated 19 million new cases annually. While conventional chemotherapeutic approaches continue to advance, target-based therapeutic strategies are increasingly recognized as effective pathways in modern drug development. A prominent biological target in current anticancer research is the selective inhibition of Topoisomerase II alpha (TOP2A). TOP2A, a crucial DNA topoisomerase, is vital for maintaining genomic integrity by mediating the cleavage and re-ligation of double-stranded DNA during essential cellular processes, such as DNA replication and transcription. Inhibiting TOP2A effectively disrupts these processes, leading to cell death. This study employed computer-aided drug design approaches to virtually screen a library of 3000 xanthone derivatives against the TOP2A target, and the results were preliminarily validated through cytotoxicity assays on the A549 and HepG2 cancer cell lines. The computational methods utilized included molecular docking, pharmacological modeling, molecular dynamics simulations, and steered molecular dynamics simulations. The virtual screening identified two highly promising HIT compounds, CID162372098 and CID156619937, that exhibited the most favorable interactions and stability profiles in relation to the TOP2A active site. The experimental results demonstrated that both hit compounds effectively exhibited significant anti-proliferative activities against the HepG2 cell line, with IC50 values of 9.54 ± 0.26 µg mL−1 (CID162372098) and 10.03 ± 0.36 12.69 ± 0.31 µg mL−1 (CID156619937), respectively. Collectively, these findings demonstrate the potential of xanthone-based scaffolds as inhibitors of TOP2A and provide a rational framework for the screening and development of novel anticancer agents.

  • New Chalcone‐Zerumbone Hybrids: Synthesis, In Vitro Anticancer Activity and Molecular Docking Study

    by Ngoc Hung Truong, Anh Tuan Do, Thi‐Kim‐Dung Le, Minh Quan Pham, Hanh Trang Luu, Kim Chi Hoang, Thi Ha Vu, Van Chinh Luu

    Chalcones and zerumbone share a common structural feature: an α,β ‐unsaturated ketone group, which is recognized as the key determinant of their anticancer activity. For the purpose of combining their promising anticancer property, eight new chalcone‐zerumbone hybrids were successfully designed and prepared via a convenient O ‐alkylation reaction between 4ʹ‐hydroxychalcones and 7‐bromozerumbone in DMF using K 2 CO 3 as a catalyst at room temperature for 18 h. As expected, all obtained chalcone hybrids with zerumbone exhibited significantly more potent cytotoxicity than their precursors, zerumbone and 4ʹ‐hydroxychalcones, against two human cancer cell lines, Hep‐G2 and MCF‐7, with IC 50 values ranging from 1.58 to 9.27 µM. Among eight prepared hybrids, 15e has the strongest activity against Hep‐G2 and MCF‐7 cell lines with IC 50 values of 1.68 and 1.58 µM, respectively. Notably, hybrids 15b, 15c, 15g , and 15 h showed good selectivity against tested cancer cell lines, with IC 50 values in normal Vero cells approximately 2–5‐fold higher than those in cancer cells. Molecular docking results also supported the findings from the experimental data.

  • Open Access

    Impact of Scutellonema curcumae sp. n. (Nematoda: Hoplolaimidae) on the Phytochemical Profile and Biological Activities of Turmeric (Curcuma longa L.)

    by Tu Thi Dinh, Quan Minh Pham, Long Quoc Pham, Chi Kim Ngo, Van Thi Thuy Nguyen, Thuong Thi Le Hoang, Tu Ngoc Ly, Linh Ngoc Nguyen, Thao Thi Phuong Nguyen, Lam Tien Do

    A new spiral nematode species, Scutellonema curcumae sp. n., was identified from the rhizosphere of turmeric (Curcuma longa L.) in the Western Highlands of Vietnam. Integrative taxonomical analysis, combining detailed morphology and molecular characterization (ITS, 28S D2–D3 rDNA, and COI mtDNA), confirmed its distinctiveness. Scutellonema curcumae sp. n. is characterized by a unique combination of a spiral body, a hemispherical lip region with four annuli, a robust stylet, and a rounded tail with a prominent scutellum, forming a highly divergent lineage within the genus. Beyond its description, this study reveals a significant inverse correlation between nematode population density and the phytochemical quality of the host. High infestation levels were associated with a marked decline in total curcuminoid content. Notably, lower nematode density favored a specific shift in the curcuminoid profile, with bisdemethoxycurcumin levels increasing by up to 250%. These phytochemical alterations directly influenced the therapeutic potential of the rhizomes: lower infestation levels resulted in significantly enhanced antioxidant capacity (lower SC50 values) and cytotoxic activity (lower IC50 against HepG2 and A549 cell lines). This work represents the first report of a Scutellonema species associated with turmeric in Vietnam and underscores its detrimental impact on the medicinal and nutraceutical value of the crop. Our findings suggest that effective nematode management is crucial not only for yield protection but as a strategic intervention in precision agriculture to optimize the secondary metabolite profiles of medicinal plants.

  • Open Access

    In silico and in vitro investigation of curcuminoid as potential TLR4/MD-2 complex inhibitors using molecular docking and molecular dynamic simulations

    by Dinh Thi Tu, Ngo Kim Chi, Le Thi Thuy Huong, Do Huu Nghi, Pham Minh Quan

    Inflammation is a key pathological process in many chronic diseases, in which the Toll-like receptor 4/myeloid differentiation factor-2 (TLR4/MD-2) complex serves as a critical upstream regulator. Curcuminoids, naturally occurring polyphenols abundant in Curcuma species cultivated in Vietnam, possess well-documented anti-inflammatory properties; however, their molecular interactions with TLR4/MD-2 remain poorly understood. In this study, an integrated in silico and in vitro strategy was employed to evaluate the anti-inflammatory potential of three major curcuminoids: curcumin, demethoxycurcumin, and bisdemethoxycurcumin. Molecular docking indicated that curcumin and bisdemethoxycurcumin exhibited strong binding affinities toward the TLR4/MD-2 complex, with docking scores of -9.29 and -9.73 kcal/mol, respectively. Molecular dynamics simulations further confirmed the structural stability of these complexes and revealed persistent key interactions. ADMET predictions suggested favorable drug-likeness and low toxicity profiles. Consistently, in vitro assays using LPS-stimulated RAW 264.7 macrophages demonstrated that curcumin and bisdemethoxycurcumin significantly inhibited nitric oxide production, with IC50 values of 121.06 ± 2.16 µM and 91.22 ± 1.58 µM, whereas demethoxycurcumin showed negligible activity. Overall, curcumin and bisdemethoxycurcumin emerge as promising natural compounds for the development of TLR4/MD-2-targeted anti-inflammatory agents.

  • Open Access

    Alteration of Lipid Bilayer Electrical Potential by Phytochemicals and Synthetic Analogs: Implications for Cellular Function

    by Svetlana S. Efimova, Quan Minh Pham, Huong Thi Thu Trinh, Long Quoc Pham, Olga S. Ostroumova

    Phytochemicals, including flavonoids, stilbenoids, alkaloids, terpenoids, and structurally related synthetic small molecules, exhibit a broad spectrum of beneficial pharmacological effects. These effects stem not only from interactions with specific protein targets but also from their capacity to modify the physical properties of biological membranes. A key membrane property influenced by these plant-derived compounds is the electrical potential drop at the membrane–water interface, which plays a crucial role in numerous cellular processes. Changes in membrane potential impact the function of embedded proteins and ion channels, thereby modulating cell signaling, transport, and pharmacological responses. This review compiles data on how diverse plant and synthetic small molecules alter membrane physical characteristics, particularly the dipole component of the boundary potential in lipid bilayers primarily composed of phosphatidylcholine, a predominant membrane lipid in mammals and fungi. In-depth analysis of structure–activity relationships in this context elucidates how various structural modifications affect the compounds’ ability to shift membrane electrical potential. Understanding these relationships can pinpoint molecular features that drive membrane interactions and facilitate the discovery and design of more potent dipole-modifying agents with therapeutic potential.